John F. Crowley - 14 Jan 2022 Form 4 Insider Report for AMICUS THERAPEUTICS, INC. (FOLD)

Role
Chairman & CEO, Director
Signature
/s/ Christian Formica, Attorney-in-Fact
Issuer symbol
FOLD
Transactions as of
14 Jan 2022
Net transactions value
-$707,732
Form type
4
Filing time
19 Jan 2022, 17:43:51 UTC
Previous filing
13 Jan 2022
Next filing
20 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FOLD Common Stock Award +239,099 +36% 894,230 14 Jan 2022 Direct F1, F2
transaction FOLD Common Stock Award +149,660 +17% 1,043,890 14 Jan 2022 Direct F3
transaction FOLD Common Stock Tax liability $620,122 -58,891 -5.6% $10.53 984,999 14 Jan 2022 Direct
transaction FOLD Common Stock Sale $87,610 -8,564 -0.87% $10.23 976,435 18 Jan 2022 Direct F4
holding FOLD Common Stock 64,895 14 Jan 2022 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FOLD Stock Options (right to buy) Award $0 +438,222 $0.000000 438,222 14 Jan 2022 Common Stock 438,222 $12.11 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted in the form of Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Amicus common stock.
F2 The Restricted Stock Units will vest in four equal annual installments beginning on January 3, 2023.
F3 Granted for the achievement of the 2019 PRSU TSR goal as determined by the Board of Directors.
F4 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F5 These options vest and become exercisable in a series of installments over a four year period, with 25% vesting on January 3, 2023 and the remaining 75% vesting ratably each month thereafter.

Remarks:

In addition to the reported transactions, Mr. Crowley also has approximately 403,000 options outstanding and exercisable at various strike prices.